Author Response: Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chun Wang(Shanghai Second People's Hospital), Gabriel Mbalaviele(Washington University in St. Louis)
Cited by 0
Related Papers
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation
|Scientific Reports|2017|108
Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals
|The Journal of Experimental Medicine|2018|103
Radiation causes tissue damage by dysregulating inflammasome–gasdermin D signaling in both host and transplanted cells
|PLoS Biology|2020|67
Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation
|Cell Death and Disease|2016|40